Combined Menin and XPO1 inhibition drive synergistic antileukemic activity in <i>KMT2A</i> r and <i>NPM1</i> -m AMLMd. Hafiz Uddin, Suresh Kumar Balasubramanian|bioRxiv (Cold Spring Harbor Laboratory)|2026Cited by 0